Intellect Neurosciences Inc. | |
Stock Exchange | Other OTC |
EPS |
$1.8 |
Market Cap |
$273.84 K |
Shares Outstanding |
6.52 M |
Public Float |
- |
Address |
550 Sylvan Avenue Englewood Cliffs New Jersey 07632 United States |
Employees | - |
Website | http://www.intellectns.com |
Updated | 09/14/2018 |
Intellect Neurosciences, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include alzheimer's, parkinson's and huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in Englewood Cliffs, NJ. |